Skip to main content

Advertisement

SpringerLink
Log in

A Semi-mechanistic Gastric Emptying Model for the Population Pharmacokinetic Analysis of Orally Administered Acetaminophen in Critically Ill Patients

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

ABSTRACT

Purpose

To develop a semi-mechanistic population pharmacokinetic model based on gastric emptying function for acetaminophen plasma concentration in critically ill patients tolerant and intolerant to enteral nutrition before and after prokinetic therapy.

Methods

Acetaminophen plasma concentrations were available from a study with 10 tolerant and 20 intolerant patients before and after prokinetic therapy with either erythromycin or metoclopramide. Population pharmacokinetic modelling was carried out in a nonlinear mixed effects analysis software, NONMEM.

Results

A four-compartment semi-mechanistic model for stomach, intestine, central and peripheral compartments was described. The rate of emptying of the stomach was described by a first-order rate parameter. The final model has two gastric emptying rate constant parameters: kg1 (1.30 h−1, RSE = 53.84%, T1/2 = 0.53 h) for the intolerant group before prokinetic therapy and kg2 (27.8 h−1, RSE = 59.35%, T1/2 = 0.025 h) for both the intolerant group after prokinetic therapy and the tolerant group. Other parameters and estimates (RSE) in the model were ka = 5.12 h−1 (28.13%), CL = 13.0 L/h (19.62%), CLD = 22.6 L/h (19.78%), V1 = 63.8 L (12.79%) and V2 = 69 L (38.70%).

Conclusions

The four-compartment semi-mechanistic population pharmacokinetic model adequately described the data. The gastric emptying half-time is improved by a factor of about 20 in the patients that are intolerant to enteral nutrition after treatment with prokinetic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

REFERENCES

  1. Nimmo WS. Drugs, diseases and altered gastric emptying. Clin Pharmacokinet. 1976;1:189–203.

    Article  CAS  PubMed  Google Scholar 

  2. Heading RC, Nimmo J, Prescott LF, Tothill P. Dependence of paracetamol absorption on rate of gastric emptying. Br J Pharmacol. 1973;47:415–21.

    CAS  PubMed  Google Scholar 

  3. Fraser DAS. Likelihood for component parameters. Biometrika. 2003;90:327–39.

    Article  Google Scholar 

  4. Fraser RJL, Bryant L. Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient. Nutr Clin Pract. 2010;25:26–31.

    Article  PubMed  Google Scholar 

  5. Nimmo WS, Heading RC, Wilson J, Tothill P, Prescott LF. Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol. 1975;2:509–13.

    CAS  PubMed  Google Scholar 

  6. Nimmo WS, Wilson J, Prescott LF. Narcotic analgesics and delayed gastric emptying during labour. Lancet. 1975;1:890–3.

    Article  CAS  PubMed  Google Scholar 

  7. Desautels SG, Hutson WR, Christian PE, Moore JG, Datz FL. Gastric-emptying response to variable oral erythromycin dosing in diabetic gastroparesis. Dig Dis Sci. 1995;40:141–6.

    Article  CAS  PubMed  Google Scholar 

  8. Hutson WR, Desautels SE, Christian PE, Moore JG, Datz FL. Gastric-emptying response to variable oral erythromycin dosing in diabetic gastroparesis. Clin Res. 1992;40:A241–1.

    Google Scholar 

  9. Holt S, Stewart MJ, Adam RD, Heading RC. Alcohol absorption, gastric-emptying and a breathalyser. Br J Clin Pharmacol. 1980;9:205–8.

    CAS  PubMed  Google Scholar 

  10. Johnson LR. Gastrointestinal hormones and their functions. Annu Rev Physiol. 1977;39:135–58.

    Article  CAS  PubMed  Google Scholar 

  11. Naslund E, Gryback P, Hellstrom PM, Jacobsson H, Holst JJ, Theodorsson E, et al. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord. 1997;21:387–92.

    Article  CAS  PubMed  Google Scholar 

  12. Sherwood L. Human physiology: from cells to systems. Belmont: Brooks/Cole; 2010.

    Google Scholar 

  13. Tarling MM, Toner CC, Withington PS, Baxter MK, Whelpton R, Goldhill DR. A model of gastric emptying using paracetamol absorption in intensive care patients. Intensive Care Med. 1997;23:256–60.

    Article  CAS  PubMed  Google Scholar 

  14. Landzinski J, Kiser TH, Fish DN, Wischmeyer PE, MacLaren R. Gastric motility function in critically ill patients tolerant vs. intolerant to gastric nutrition. JPEN J Parenter Enteral Nutr. 2008;32:45–50.

    Article  PubMed  Google Scholar 

  15. MacLaren R, Kiser TH, Fish DN, Wischmeyer PE. Erythromycin vs. metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients. J Parenter Enteral Nutr. 2008;32:412–9.

    Article  CAS  Google Scholar 

  16. MacLaren R, Kiser T, Fish D, Wischmeyer P. Erythromycin versus metoclopramide for facilitating gastric emptying and tolerance to intra-gastric nutrition. Crit Care Med. 2007;35:A192–2.

    Article  Google Scholar 

  17. Landzinski J, Kiser T, Fish D, MacLaren R, Wischmeyer P. Gastric motility function in critically-ill patients tolerant versus intolerant to gastric nutrition. Crit Care Med. 2007;35:A193–3.

    Google Scholar 

  18. Verbeke K. Will the 13C-octanoic acid breath test ever replace scintigraphy as the gold standard to assess gastric emptying? Neurogastroenterol Motil. 2009;21:1013–6.

    Article  CAS  PubMed  Google Scholar 

  19. Clements JA, Heading RC, Nimmo WS, Prescott LF. Kinetics of acetaminophen absorption and gastric-emptying in man. Clin Pharmacol Ther. 1978;24:420–31.

    CAS  PubMed  Google Scholar 

  20. Clements JA, Nimmo WS, Heading RC, Prescott LF. Physiologically-based pharmacokinetic model for absorption of oral paracetamol in man. J Pharm Pharmacol. 1978;30:P60–0.

    Google Scholar 

  21. Heading RC. Gastric emptying: a clinical perspective. Clin Sci (Lond). 1982;63:231–5.

    CAS  Google Scholar 

  22. Holt S, Reid J, Taylor TV, Tothill P, Heading RC. Gastric emptying of solids in man. Gut. 1982;23:292–6.

    Article  CAS  PubMed  Google Scholar 

  23. Braden B, Adams S, Duan LP, Orth KH, Maul FD, Lembcke B, et al. The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology. 1995;108:1048–55.

    Article  CAS  PubMed  Google Scholar 

  24. Sanaka M, Urita Y, Sugimoto M, Yamamoto T, Kuyama Y. Comparison between gastric scintigraphy and the [13C]-acetate breath test with Wagner-Nelson analysis in humans. Clin Exp Pharmacol Physiol. 2006;33:1239–43.

    Article  CAS  PubMed  Google Scholar 

  25. Sanaka M, Yamamoto T, Ishii T, Kuyama Y. The Wagner-Nelson method can generate an accurate gastric emptying flow curve from (CO2)-C-13 data obtained by a C-13-labeled substrate breath test. Digestion. 2004;69:71–8.

    Article  PubMed  Google Scholar 

  26. Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS. [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology. 1997;112:1155–62.

    Article  CAS  PubMed  Google Scholar 

  27. Keller J, Andresen V, Wolter J, Layer P, Camilleri M. Influence of clinical parameters on the results of 13C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil. 2009;21:1039–e1083.

    Article  CAS  PubMed  Google Scholar 

  28. Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology. 1993;104:1640–7.

    CAS  PubMed  Google Scholar 

  29. Sanaka M, Yamamoto T, Kuyama Y. Theoretical flaws in the gastric emptying breath test: why is it dubious? Dig Dis Sci. 2005;50:15–7.

    Article  PubMed  Google Scholar 

  30. Holt S, Heading RC, Clements JA, Tothill P, Prescott LF. Acetaminophen absorption and metabolism in celiac disease and Crohn’s disease. Clin Pharmacol Ther. 1981;30:232–8.

    Article  CAS  PubMed  Google Scholar 

  31. Balant LP, Gex-Fabry M. Modelling during drug development. Eur J Pharm Biopharm. 2000;50:13–26.

    Article  CAS  PubMed  Google Scholar 

  32. FDA. US Department of Health and Human Services, Food and Drug Administration. Innovation or stagnation? Challenge and opportunity on the critical path to new medical products. (2004).

  33. Zhang L, Sinha V, Forgue S, Callies S, Ni L, Peck R, et al. Model-based drug development: the road to quantitative pharmacology. J Pharmacokinet Pharmacodyn. 2006;33:369–93.

    Article  CAS  PubMed  Google Scholar 

  34. Aarons L. The estimation of population pharmacokinetic parameters using an EM algorithm. Comput Methods Programs Biomed. 1993;41:9–16.

    Article  CAS  PubMed  Google Scholar 

  35. Beal S, Sheiner LB, Boeckmann A, Bauer RJ. NONMEM User’s Guides. (1989–2009). Icon Development Solutions, Ellicott City, MD, USA (2009).

  36. Lindbom L, Ribbing J, Jonsson EN. Perls-speaks-NONMEM (PsN)–a Perl module for NONMEM related programming. Comput Methods Programs Biomed. 2004;75:85–94.

    Article  PubMed  Google Scholar 

  37. Lindbom L, Pihlgren P, Jonsson N. PsN-Toolkit–A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed. 2005;79:241–57.

    Article  PubMed  Google Scholar 

Download references

ACKNOWLEDGEMENTS

KO was sponsored by a fellowship from Novartis, and the research was based at the Centre for Applied Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Manchester, UK. CAPKR is supported by the following consortium members: Eli Lilly, GlaxoSmithKline, Pfizer and Servier.

Author information

Authors and Affiliations

  1. Pharmacokinetic Research, School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK

    Kayode Ogungbenro

  2. Centre for Applied Pharmacokinetic Research, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK

    Leon Aarons

  3. GlaxoSmithKline, Research Triangle Park, North Carolina, USA

    Lakshmi Vasist, George Dukes & Malcolm Young

  4. University of Colorado Health Science Center, Denver, Colorado, USA

    Robert Maclaren

  5. School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK

    Leon Aarons

Authors
  1. Kayode Ogungbenro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lakshmi Vasist
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Maclaren
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George Dukes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Malcolm Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Leon Aarons
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kayode Ogungbenro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ogungbenro, K., Vasist, L., Maclaren, R. et al. A Semi-mechanistic Gastric Emptying Model for the Population Pharmacokinetic Analysis of Orally Administered Acetaminophen in Critically Ill Patients. Pharm Res 28, 394–404 (2011). https://doi.org/10.1007/s11095-010-0290-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-010-0290-8

KEY WORDS

Search

Navigation